Literature DB >> 12615438

Protective immunity against pasteurellosis in cattle, induced by Pasteurella haemolytica ghosts.

J Marchart1, M Rehagen, G Dropmann, M P Szostak, S Alldinger, S Lechleitner, T Schlapp, S Resch, W Lubitz.   

Abstract

Pasteurella haemolytica is a cattle pathogen of significant economic impact. An effective vaccine against bovine pneumonic pasteurellosis is therefore of high importance. Apart from economic concerns, pasteurellosis caused by P. haemolytica is a serious disease leading to death in cattle if it remains untreated. In this study P. haemolytica-ghosts are presented as a promising vaccine candidate in cattle. To obtain sufficient vaccination material a fermentation protocol for P. haemolytica-ghost production was established. With the obtained experimental P. haemolytica-ghost vaccine, cattle immunization studies were performed based on a Pasteurella cattle challenge model developed specifically for vaccine validation. It was shown that protective immunization of cattle against homologous challenge was induced by adjuvanted P. haemolytica-ghosts. The level of protection was similar to a commercially available vaccine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615438     DOI: 10.1016/s0264-410x(02)00635-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.

Authors:  Ulrike Beate Mayr; Christoph Haller; Wolfgang Haidinger; Alena Atrasheuskaya; Eugenij Bukin; Werner Lubitz; Georgy Ignatyev
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 2.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

3.  Immunological characterization of the chemically prepared ghosts of Salmonella Typhimurium as a vaccine candidate.

Authors:  Sameh Rabea; Aymen S Yassin; Aly Fahmy Mohammed; Mounir M Salem-Bekhit; Fars K Alanazi; Eman Amin Esmail; Nayera A Moneib; Abd Elgawad M Hashem
Journal:  BMC Vet Res       Date:  2022-02-18       Impact factor: 2.741

4.  Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7.

Authors:  Kun Cai; Wei Tu; Yuenan Liu; Tao Li; Hui Wang
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

Review 5.  Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics.

Authors:  Aditya Ganeshpurkar; Ankit Ganeshpurkar; Vikas Pandey; Abhishek Agnihotri; Divya Bansal; Nazneen Dubey
Journal:  Int J Pharm Investig       Date:  2014-01

6.  A Novel and Efficient High-Yield Method for Preparing Bacterial Ghosts.

Authors:  Yi Ma; Liu Cui; Meng Wang; Qiuli Sun; Kaisheng Liu; Jufang Wang
Journal:  Toxins (Basel)       Date:  2021-06-13       Impact factor: 4.546

7.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

8.  Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.

Authors:  Aleksandra Inic-Kanada; Marijana Stojanovic; Simone Schlacher; Elisabeth Stein; Sandra Belij-Rammerstorfer; Emilija Marinkovic; Ivana Lukic; Jacqueline Montanaro; Nadine Schuerer; Nora Bintner; Vesna Kovacevic-Jovanovic; Ognjen Krnjaja; Ulrike Beate Mayr; Werner Lubitz; Talin Barisani-Asenbauer
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

9.  Peptidoglycan-Free Bacterial Ghosts Confer Enhanced Protection against Yersinia pestis Infection.

Authors:  Svetlana V Dentovskaya; Anastasia S Vagaiskaya; Mikhail E Platonov; Alexandra S Trunyakova; Sergei A Kotov; Ekaterina A Krasil'nikova; Galina M Titareva; Elizaveta M Mazurina; Tat'yana V Gapel'chenkova; Rima Z Shaikhutdinova; Sergei A Ivanov; Tat'yana I Kombarova; Vladimir N Gerasimov; Vladimir N Uversky; Andrey P Anisimov
Journal:  Vaccines (Basel)       Date:  2021-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.